Header Logo

Connection

DANIEL DESALVO to Blood Glucose Self-Monitoring

Back to Details
This is a "connection" page, showing publications DANIEL DESALVO has written about Blood Glucose Self-Monitoring.
DANIEL DESALVO
Connection Strength
6.545
Blood Glucose Self-Monitoring
  1. Social Determinant of Health Impact on Diabetes Device Use and Clinical Outcomes in Youth with Type 1 Diabetes. Pediatr Diabetes. 2023; 2023:4751595.
    View in: PubMed
    Score: 0.771
  2. Diabetes Device Use and Glycemic Control among Youth with Type 1 Diabetes: A Single-Center, Cross-Sectional Study. J Diabetes Res. 2018; 2018:5162162.
    View in: PubMed
    Score: 0.536
  3. Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative. Pediatr Diabetes. 2018 11; 19(7):1271-1275.
    View in: PubMed
    Score: 0.533
  4. Effect of lipohypertrophy on accuracy of continuous glucose monitoring in patients with type 1 diabetes. Diabetes Care. 2015 Oct; 38(10):e166-7.
    View in: PubMed
    Score: 0.437
  5. Accuracy evaluation of blood glucose monitoring systems in children on overnight closed-loop control. J Diabetes Sci Technol. 2014 Sep; 8(5):969-73.
    View in: PubMed
    Score: 0.401
  6. Continuous glucose monitoring: current use and future directions. Curr Diab Rep. 2013 Oct; 13(5):657-62.
    View in: PubMed
    Score: 0.384
  7. Safety and Glycemic Outcomes Among Youth With New-Onset Type 1 Diabetes Using a Tubeless Automated Insulin Delivery System. J Diabetes Res. 2026; 2026(1):e2896084.
    View in: PubMed
    Score: 0.224
  8. A multimodal physiological dataset for non-invasive blood glucose estimation. Sci Data. 2025 Nov 19; 12(1):1822.
    View in: PubMed
    Score: 0.222
  9. Early Continuous Glucose Monitor Use in Children and Adolescents With Type 1 Diabetes: Rates of Initiation and Impact on Glycemic Outcomes. Diabetes Care. 2025 May 01; 48(5):768-775.
    View in: PubMed
    Score: 0.214
  10. International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024 Diabetes Technologies: Glucose Monitoring. Horm Res Paediatr. 2024; 97(6):615-635.
    View in: PubMed
    Score: 0.210
  11. Real-World Insights Into Hypoglycemia Risk While Driving in Teens and Young Adults With Type 1 Diabetes. Pediatr Diabetes. 2025; 2025:5053872.
    View in: PubMed
    Score: 0.210
  12. Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod? 5 Automated Insulin Delivery System. Diabetes Technol Ther. 2024 06; 26(6):383-393.
    View in: PubMed
    Score: 0.197
  13. Continuous Glucose Monitoring Provides Durable Glycemic Benefit in Adolescents and Young Adults with Type 1 Diabetes: 12-Month Follow-Up Results. Pediatr Diabetes. 2023; 2023:6718115.
    View in: PubMed
    Score: 0.193
  14. Adolescent- and Young Adult-Reported Outcomes and Use of Continuous Glucose Monitoring Features: A Report from the CITY Trial. Pediatr Diabetes. 2023; 2023:6906023.
    View in: PubMed
    Score: 0.191
  15. Transatlantic Comparison of Pediatric Continuous Glucose Monitoring Use in the Diabetes-Patienten-Verlaufsdokumentation Initiative and Type 1 Diabetes Exchange Quality Improvement Collaborative. Diabetes Technol Ther. 2022 12; 24(12):920-924.
    View in: PubMed
    Score: 0.178
  16. Hybrid Closed-Loop Systems and Glycemic Outcomes in Children and Adults With Type 1 Diabetes: Real-World Evidence From a U.S.-Based Multicenter Collaborative. Diabetes Care. 2022 08 01; 45(8):e118-e119.
    View in: PubMed
    Score: 0.177
  17. Long-term Continuous Glucose Monitor Use in Very Young Children With Type 1 Diabetes: One-Year Results From the SENCE Study. J Diabetes Sci Technol. 2023 Jul; 17(4):976-987.
    View in: PubMed
    Score: 0.173
  18. Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational Study. J Diabetes Sci Technol. 2023 03; 17(2):322-328.
    View in: PubMed
    Score: 0.167
  19. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2020 06 16; 323(23):2388-2396.
    View in: PubMed
    Score: 0.153
  20. Greater parental comfort with lower glucose targets in young children with Type 1 diabetes using continuous glucose monitoring. Diabet Med. 2019 11; 36(11):1508-1510.
    View in: PubMed
    Score: 0.143
  21. Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes. Diabetes Technol Ther. 2019 09; 21(9):493-498.
    View in: PubMed
    Score: 0.143
  22. Effect of acetaminophen on CGM glucose in an outpatient setting. Diabetes Care. 2015 Oct; 38(10):e158-9.
    View in: PubMed
    Score: 0.109
  23. Remote glucose monitoring in camp setting reduces the risk of prolonged nocturnal hypoglycemia. Diabetes Technol Ther. 2014 01; 16(1):1-7.
    View in: PubMed
    Score: 0.096
  24. SCI - U: Validation of an updated Self-Care Inventory for contemporary diabetes management in adolescents with type 1 diabetes. Diabetes Res Clin Pract. 2025 Jun; 224:112218.
    View in: PubMed
    Score: 0.053
  25. Real-World Evidence of Omnipod? 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes. Diabetes Technol Ther. 2024 08; 26(8):514-525.
    View in: PubMed
    Score: 0.049
  26. Two Years with a Tubeless Automated Insulin Delivery System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 Diabetes. Diabetes Technol Ther. 2024 01; 26(1):11-23.
    View in: PubMed
    Score: 0.048
  27. Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice. Endocr Rev. 2023 03 04; 44(2):254-280.
    View in: PubMed
    Score: 0.046
  28. ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring. Pediatr Diabetes. 2022 12; 23(8):1390-1405.
    View in: PubMed
    Score: 0.045
  29. A Real-World Prospective Study of the Safety and Effectiveness of the Loop Open Source Automated Insulin Delivery System. Diabetes Technol Ther. 2021 05; 23(5):367-375.
    View in: PubMed
    Score: 0.040
  30. Feature-Based Machine Learning Model for Real-Time Hypoglycemia Prediction. J Diabetes Sci Technol. 2021 07; 15(4):842-855.
    View in: PubMed
    Score: 0.038
  31. Characteristics of adult- compared to childhood-onset type 1 diabetes. Diabet Med. 2020 12; 37(12):2109-2115.
    View in: PubMed
    Score: 0.038
  32. Time spent outside of target glucose range for young children with type 1 diabetes: a continuous glucose monitor study. Diabet Med. 2020 08; 37(8):1308-1315.
    View in: PubMed
    Score: 0.038
  33. Insulin Pump Use in Young Children with Type 1 Diabetes: Sociodemographic Factors and Parent-Reported Barriers. Diabetes Technol Ther. 2017 06; 19(6):363-369.
    View in: PubMed
    Score: 0.031
  34. Early Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 Diabetes. J Diabetes Sci Technol. 2016 11; 10(6):1268-1276.
    View in: PubMed
    Score: 0.030
  35. Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp. Diabetes Care. 2014 Aug; 37(8):2310-6.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.